Insilico validation and comparison of antifungal competence and druglikeness of some natural xanthones – A step towards antimycotic therapeutics

Sharma, 2021, Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum, J. Laryngol. Otol., 1 De-Shazo, 1998, Fungal sinusitis, Am. J. Med. Sci., 316, 39 Qin, 2020, Antibacterial activities with the structure-activity relationship of coumarin derivatives, Eur. J. Med. Chem., 207, 10.1016/j.ejmech.2020.112832 Qin, 2020, Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review, Eur. J. Med. Chem., 193, 10.1016/j.ejmech.2020.112215 Qin, 2020, Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA), Eur. J. Med. Chem., 194, 10.1016/j.ejmech.2020.112245 Manukumar, 2017, Novel T-C@AgNPs mediated biocidal mechanism against biofilm associated methicillin-resistant Staphylococcus aureus (Bap-MRSA) 090 cytotoxicity and its molecular docking studies, Med. Chem. Commun., 8, 2181, 10.1039/C7MD00486A Zhang, 2018, Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development, Microbiol. Res., 212–213, 59, 10.1016/j.micres.2018.05.002 Zhang, 2018, Role of BP*C@AgNPs in Bap-dependent multicellular behavior of clinically important methicillin-resistant Staphylococcus aureus (MRSA) biofilm adherence: a key virulence study, Microb. Pathog., 123, 275, 10.1016/j.micpath.2018.07.025 Li, 2018, Multi-targeted dihydrazones as potent biotherapeutics, Bioorg. Chem., 81, 389, 10.1016/j.bioorg.2018.08.024 Rakesh, 2018, Combating a master manipulator: Staphylococcus aureus immunomodulatory molecules as targets for combinatorial drug discovery, ACS Comb. Sci., 20, 681, 10.1021/acscombsci.8b00088 Negi, 2013, Naturally occurring xanthones: chemistry and biology, J. Appl. Chem., 9 Gopalakrishnan, 1997, Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives, J. Nat. Prod., 60, 519, 10.1021/np970165u Chilpa, 1997, Antifungal xanthones from calophyllum brasiliensis heartwood, J. Chem. Ecol., 23, 1901, 10.1023/B:JOEC.0000006459.88330.61 Fukai, 2003, Antifungal agents from the roots of Cudrania cochinchinensis against Candida Cryptococcus and Aspergillus species, J. Nat. Prod., 66, 1118, 10.1021/np030024u Ioset, 1998, Antifungal xanthones from roots of marila laxiflora, Pharmaceut. Biol., 36, 103, 10.1076/phbi.36.2.103.4603 Pinto, 1994, Xanthone and antifungal constituents from Monnina obtusifolia, Phytochemistry, 37, 875, 10.1016/S0031-9422(00)90375-3 Saeed Khan, 1998, Article buch et ham, 40, 175 Diserens, 1989, Novel Prenylated xanthones from Garcinia gerrardii, HARVEY. HELVETICA, 72, 1001 Rath, 1996, Xanthones from Hypericum roeperanum, Phytochemistry, 43, 513, 10.1016/0031-9422(96)00284-1 Pinto, 2011, Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography, Chem. Biol. Drug Des., 77, 212, 10.1111/j.1747-0285.2010.01072.x Morel, 2002, New and antifungal xanthones from Calophyllum caledonicum, Planta Med., 68, 41, 10.1055/s-2002-19867 Hostettmann, 2000, The potential of African plants as a source of drugs, Curr. Org. Chem., 4, 973, 10.2174/1385272003375923 Marston, 1993, Xanthones from polygala nyikensis, Phytochemistry, 33, 809, 10.1016/0031-9422(93)85279-Z Feng, 2020, Xanthones A promising anti-inflammatory scaffold: structure activity and drug likeness analysis, A Review Molecules, 25, 598, 10.3390/molecules25030598 Daniel, 2019, Structures activities and drug-likeness of anti infective xanthone derivatives isolated from the marine environment, A Review Molecules, 24, 243, 10.3390/molecules24020243 Bernal and Ericsson Coy-Barrera, 2015, Molecular docking and Mulvariate analysis of xanthones as antimicrobial and antiviral agents, Molecules, 20, 13165, 10.3390/molecules200713165 Milewski, 2002, Glucosamine-6-phosphate synthase-the multi-facets enzyme, Biochem. Biophys. Acta., 1597, 173 Daina, 2017, SwissADME: a free web tool to evaluate pharmacokinetics drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep., 7, 10.1038/srep42717 Frisch, 2009, vol. 28 Becke, 1993, A new mixing of Hartree-Fock and local density functional theories, J. Chem. Phys., 98, 1372, 10.1063/1.464304 Lee, 1988, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Phys. Rev. B, 37, 785, 10.1103/PhysRevB.37.785 Hariharan, 1973, The influence of polarization functions on molecular orbital hydrogenation energies, Theor. Chim. Acta, 28, 213, 10.1007/BF00533485 Huey, 2007, Semiempirical free energy force field with charge-based desolvation, J. Comput. Chem., 28, 1145, 10.1002/jcc.20634 Morris, 1988, Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem., 19, 1639, 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Daina, 2016, BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules, ChemMedChem, 11, 1117, 10.1002/cmdc.201600182 Lipinski, 2012, J Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 64, 4, 10.1016/j.addr.2012.09.019 Vijesh, 2013, Molecular docking studies of some new imidazole derivative, Arab. J. Chem., 6, 197, 10.1016/j.arabjc.2011.10.007 Ghose, 1999, A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases, J. Comb. Chem., 1, 55, 10.1021/cc9800071 Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem., 45, 2615, 10.1021/jm020017n Egan, 2002, Prediction of drug absorption using multivariate statistics, J. Med. Chem., 43, 3867, 10.1021/jm000292e Muegge, 2001, Simple selection criteria for drug-like chemical matter, J. Med. Chem., 44, 1841, 10.1021/jm015507e Leeson, 2007, The influence of drug-like concepts on decision-making in medicinal chemistry, Nat. Rev. Drug Discov., 6, 881, 10.1038/nrd2445 Pajouhesh, 2005, Medicinal chemical properties of successful central nervous system. Drugs, NeuroRx, 2, 541, 10.1602/neurorx.2.4.541 Edward, 2008, vol. 56 Delaney, 2004, ESOL: estimating aqueous solubility directly from molecular structure, J. Chem. Inf. Model., 44, 1000 Ali, 2012, Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area, J. Chem. Inf. Model., 52, 420, 10.1021/ci200387c Thiebaut, 1987, Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal human tissues, Proc. Natl. Acad. Sci. U.S.A., 84, 10.1073/pnas.84.21.7735 Martin, 2004, Importance of P-glycoprotein at blood-tissue barriers, Trends Pharmacol. Sci., 25, 424 Konig, 2013, Transporters and drug-drug interactions: important determinants of drug disposition and effects, Pharmacol. Rev., 65, 10.1124/pr.113.007518 Guengerich, 2008, Cytochrome p450 and chemical toxicology, Chem. Res. Toxicol., 21, 70, 10.1021/tx700079z Van Waterschoot, 2011, A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice, Pharmacol. Rev., 63, 390, 10.1124/pr.110.002584 Baell, 2010, New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J. Med. Chem., 53, 2719, 10.1021/jm901137j